Summary
This prediction ended on 03.11.22 with a price of €46.20. The price of Roku decreased from the start of the prediction. Compared to the start price this resulted in a performance of -17.36%. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Roku | 3.029% | 3.029% | 23.696% | 109.835% |
| iShares Core DAX® | 3.002% | 3.742% | 24.169% | 65.664% |
| iShares Nasdaq 100 | 2.966% | 1.308% | 9.141% | 111.170% |
| iShares Nikkei 225® | 5.606% | 4.472% | 21.237% | 55.883% |
| iShares S&P 500 | 2.312% | 1.880% | 6.333% | 67.956% |
According to BiotechBee what are the pros and cons of Roku for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by BiotechBee for this prediction
In the thread Roku diskutieren
Sell mit Kursziel 43,0